WEBINARS
Our webinars allow users to learn from experts and earn continuing education credits on industry topics, progress in research, services available, and more.
Show More
-
JUN 01, 2022 | 9:00 AM
Date: June 01, 2022 Time: 9:00am (PST), 12:00pm (EST), 6:00pm (CEST) The enumeration and analysis of blood cells with automated haematology analysers have significantly improved in recent ye... -
MAY 31, 2022 | 11:00 AM
Date: May 31, 2022 Time: 11:00am (PST), 2:00pm (EST), 8:00pm (CEST) In February of this year Minnesota became the first state in the U.S. to screen every newborn for congenital CMV. This was...
-
MAY 31, 2022 | 9:00 AM
Date: May 31, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) Introducing Nanostring’s latest spatial platform, CosMx Spatial Molecular Imager (SMI). Offering high-plex, multiomi...
-
MAY 31, 2022 | 6:00 AM
Date: May 31, 2022 Time: 6:00am (PDT), 9:00am (EDT), 3:00pm (CEST) This webinar will introduce why deep structural elucidation of drug candidate metabolism is a requisite part of early- to l...
-
MAY 26, 2022 | 9:00 AM
Date: May 26, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) In early drug development, lead clone selection requires large number of clones screening in cell line development. Develo...
-
MAY 26, 2022 | 8:00 AM
Date: May 26, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST), 12:00am JST The industry still relies heavily on PCR and cell-based cloning. Both are decades old methodologies. However,...
-
MAY 25, 2022 | 10:00 AM
Date: May 25, 2022 Time: 10:00am (PDT), 1:00pm (EDT), 7:00pm (CEST) Programmable RNA base editors are excellent tools to modify RNA transcripts at precise locations or designated hotspots. P...
-
MAY 24, 2022 | 11:00 AM
Date: May 24, 2022 Time: 11:00am (PDT), 2:00pm (EDT), 7:00pm (CEST) NGS tumor profiling has become the mainstay of modern cancer therapy. Several NCCN-guided and FDA-approved therapies are c...
-
MAY 24, 2022 | 9:00 AM
Date: May 24, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) Recent breakthroughs in autologous cellular therapies have generated tremendous excitement for the industry; however, thes...
-
MAY 19, 2022 | 8:00 AM
Date: May 19, 2022 Time: 8:00am (PDT), 11:00pm (EDT), 5:00pm (CEST) Mass spectrometry (MS)-based proteomic technologies are increasingly applied in a clinical context for disease classific...
-
MAY 19, 2022 | 6:00 AM
Date: May 19, 2022 Time: 6:00am (PST), 9:00am (EST), 3:00pm (CEST) In the age of evidence-based medicine, evidence-informed decision making is rapidly gaining influence. However, clinical pe...
-
MAY 17, 2022 | 9:00 AM
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
-
MAY 17, 2022 | 8:00 AM
Date: May 17, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) The CRISPR-Cas9 system provides researchers a powerful tool for manipulation of cells to create disease models, reporter c...
-
MAY 17, 2022 | 7:00 AM
Date: May 17, 2022 Time: 7:00am (PDT), 10:00am (EDT), 4:00pm (CEST) Monoclonal antibody (mAb) is generated from a single clone of an antibody-producing cell and recognizes one specific epitop...
-
MAY 12, 2022 | 9:00 AM
Date: May 12, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CET) The ability to move rapidly through the Design-Generate-Test-Learn (DGTL) cycle is essential for effective forward engineer...
-
MAY 12, 2022 | 8:00 AM
Date: May 12, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Cell culture is key for efficient and reliable T cell workflows, be it activation/ and expansion, T helper cell polarizati...
-
MAY 11, 2022 | 12:00 PM
Date: May 11, 2022 Time: 12:00pm (PDT), 3:00pm (EDT), 9:00pm (CEST) In this presentation, Dr. Courtney Miller and Daniel Rodrigues Oliveira, M.S. will describe the efforts of the California...
-
MAY 05, 2022 | 9:00 AM
Date: May 5, 2022 Time: 9:00am (PDT), 12:00pm (EDT) In a time when there is global urgency around producing and deploying as many COVID-19 vaccines as...
-
MAY 03, 2022 | 8:00 AM
Cancer is a disease of the genome, and as such, tools that can analyze the genome are instrumental in understanding the mechanisms that lead to cancer, detecting cancerous cells, and providi...
-
MAY 03, 2022 | 8:00 AM
Date: May 03, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) CRISPR-Cas9 is one of the most commonly leveraged non-viral editing tools to engineer cells for therapeutics applications....
-
APR 29, 2022 | 12:00 AMC.E. CREDITS
Discover how preanalytical errors impact coagulation testing and learn case-based strategies to improve lab accuracy in our webinar....
APR 28, 2022 | 9:00 AM
Date: April 28, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CET) During previous webinars we have discussed the global impact of antimicrobial resistance (AMR) infections, explored biolo...
APR 28, 2022 | 8:00 AM
Date: April 28, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Human pluripotent stem cells (PSCs) and their derivatives hold great potentials in...
APR 27, 2022 | 9:00 AM
Date: April 27, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) Abnormal accumulation of misfolded tau protein in filaments characterizes more than 20 neurodegenerative diseases—c...
APR 27, 2022 | 8:00 AM
Date: April 27, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CET) Join Mick D. Edmonds, PhD, Assistant Professor and Director, Genetic and Genomic Sciences Program at University of Alabam...
APR 26, 2022 | 11:00 AM
Date: April 26, 2022 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEST) Balance between spatial resolution, temporal resolution, and sample viability is key to extracting more data from your i...
APR 26, 2022 | 8:00 AM
Date: April 26, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) C-C motif chemokine receptor-like 2 (CCRL2), is a non-signaling 7TM receptor, referred to as an atypical chemokine recep...
-
NOV 06, 2025Precision Oncology Showcase
-
DEC 05, 2025Stago EdVantage Virtual University
-
MAR 04, 2026Neuroscience Virtual Event Series 2026
-
MAR 18, 2026Laboratory Automation Virtual Event Series 2026
- See More
-
NOV 05, 2025
-
NOV 05, 2025
-
NOV 05, 2025
-
NOV 05, 2025
- See More
